MedPath

rTMS in Treatment of Obsessive Compulsive Disorder (OCD)

Not Applicable
Completed
Conditions
Obsessive Compulsive Disorder
Interventions
Device: sham (placebo)
Device: repetitive transcranial magnetic stimulation
Registration Number
NCT00616486
Lead Sponsor
Queen's University
Brief Summary

Low frequency (1Hz) rTMS applied bilaterally and simultaneously over SMA for 6 weeks in addition to the standard treatment regimen for OCD, will lead to significant improvement in patients' symptoms. The clinical improvement detected by YBOCS, CGI and SF-36 QOLS scores will be statistically significant in active treatment group compared to sham (placebo) treatment group.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
24
Inclusion Criteria
  • signed patient informed consent;
  • primary obsessive compulsive disorder;
  • YBOCS score at least 20;
  • males/females 18-65yrs;
  • treated with adequate dose of SSRI at least 8 weeks at some stage of illness;
  • currently using adequate, stable dose of SSRI at least 4 weeks but not responding.
Exclusion Criteria
  • schizophrenia, other psychotic disorders, bipolar I, current major depressive disorder (HDRS(17)>18, substance/alcohol dependence within last 6 months;
  • severe axis II;
  • suicidal score>=6 on MINI;
  • metallic implant in cranium;
  • severe/unstable medical conditions;
  • not responding to ECT or had TMS in last 6 months;
  • history epilepsy;
  • neurological disorder leading to increased intracranial pressure;
  • severe cardiac disorder/intracardiac lines, pacemakers;

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
2sham (placebo)-
1repetitive transcranial magnetic stimulation-
Primary Outcome Measures
NameTimeMethod
Yale-Brown Obsessive Compulsive Scale (YBOCS)pre, week 1, 2, 4, 6, 8, 12
Secondary Outcome Measures
NameTimeMethod
Clinical Global Impressionpre, week 1, 2, 4, 6, 8, 12
Hamilton Depression Rating Scale-21(HDRS)pre, week 1, 2, 4, 6, 8, 12
Hamilton Anxiety Rating Scale (HARS)pre, week 1, 2, 4, 6, 8, 12
Visual Analogue Scalepre, week 1, 2, 4, 6, 8, 12
Pittsburgh Sleep Quality Index (PSQI)pre, week 1, 2, 4, 6, 8, 12
SF-36 QOLS version (1)pre, week 1, 2, 4, 6, 8, 12

Trial Locations

Locations (3)

Military Medical Academy

🇧🇬

Sofia, Bulgaria

Providence Care, Mental Health Services

🇨🇦

Kingston, Ontario, Canada

Dokuz Eylul University

🇹🇷

Izmir, Turkey

© Copyright 2025. All Rights Reserved by MedPath